My Photo
Blog powered by Typepad

Powered by Rollyo

Blogroll

IP.com Library Search

« China and India Patent Law Panel | Main | ITC Commission Issues Favorable Ruling in Kodak Patent Case Against Apple and RIM »

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83452483069e201538f8d9eb8970b

Listed below are links to weblogs that reference Somaxon Pharmaceuticals Files Patent Infringement Case Against Mylan:

Comments

pharma feedback

The US Court of Appeals for the Federal Circuit has overturned a prior ruling by the US District Court for the District of New Jersey and upheld the validity of Eli Lilly's method-of-use patent on the attention deficit hyperactivity disorder drug, Strattera (atomoxetine). In the case of Lilly versus Actavis Elizabeth L.L.C. et al, the Court ruled in favour of Lilly, upholding the method-of-use patent, which provides protection for Strattera through May 2017.

pharma reviews

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

The comments to this entry are closed.